Immediate and residual effects of tamoxifen and ethynylestradiol in the female rat hypothalamus

Brain Research

Volumn 978, Issue 1-2, 2003, Pages 185-193

  Patisaul, Heather B ^a   Aultman, Eleni A ^a   Bielsky, Isadora F ^a   Young, Larry J ^a   Wilson, Mark E ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

ER ; ER ; Estrogen; Hypothalamus; Progesterone; Selective estrogen receptor modulator

Indexed keywords

ESTRADIOL; ETHINYLESTRADIOL; OXYTOCIN RECEPTOR; SESAME SEED OIL; SILASTIC; TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; FEMALE; GENE EXPRESSION; HYPOTHALAMUS; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; THALAMUS VENTRAL NUCLEUS; UTERUS WEIGHT; WEIGHT GAIN;

EID: 0038094466     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(03)02807-5     Document Type: Article

References (37)

1. Ahdieh H.B., Mayer A.D., Rosenblatt J.S. Effects of brain antiestrogen implants on maternal behavior and on postpartum estrus in pregnant rats. Neuroendocrinology. 45:1987;201-207.
2. Boettger-Tong H., Murthy L., Chiappetta C., Kirkland J.L., Goodwin B., Adlercreutz H., Stancel G.M., Mäkelä S. A case of a laboratory animal feed with high estrogenic activity and its impact on in vivo responses to exogenously administered estrogens. Environ. Health Perspect. 106:1998;369-373.
3. Breton C., Zingg H.H. Expression and region-specific regulation of the oxytocin receptor gene in rat brain. Endocrinology. 138:1997;1857-1862.
4. Caldwell J.D., Johns J.M., Faggin B.M., Senger M.A., Pedersen C.A. Infusion of an oxytocin antagonist into the medial preoptic area prior to progesterone inhibits sexual receptivity and increases rejection in female rats. Horm. Behav. 28:1994;288-302.
5. Cosman F., Lindsay R. Selective estrogen receptor modulators: clinical spectrum. Endocr. Rev. 20:1999;418-434.
6. Cyr M., Ghribi O., Thibault C., Morissette M., Landry M., Di Paolo T. Ovarian steroids and selective estrogen receptor modulators activity on rat brain NMDA and AMPA receptors. Brain Res. Brain Res. Rev. 37:2001;153-161.
7. Day R. Quality of life and tamoxifen in a breast cancer prevention trial: a summary of findings from the NSABP P-1 study. National Surgical Adjuvant Breast and Bowel Project. Ann. N. Y. Acad. Sci. 949:2001;143-150.
8. Diel P. Tissue-specific estrogenic response and molecular mechanisms. Toxicol. Lett. 127:2002;217-224.
9. Etgan A.M., Shamamian P. Regulation of estrogen-stimulated lordosis behavior and hypothalamic progestin receptor induction by antiestrogens in female rats. Horm. Behav. 20:1986;166-180.
10. Fitzpatrick S.L., Berrodin T.J., Jenkins S.F., Sindoni D.M., Deecher D.C., Frail D.E. Effect of estrogen agonists and antagonists on induction of progesterone receptor in a rat hypothalamic cell line. Endocrinology. 140:1999;3928-3937.
11. Gajdos C., Jordan V.C. Selective estrogen receptor modulators as a new therapeutic drug group: concept to reality in a decade. Clin. Breast Cancer. 2:2002;272-281.
12. Goldstein S.R. The effect of SERMs on the endometrium. Ann. N. Y. Acad. Sci. 949:2001;237-242.
13. Janssens J.P., Billiet G., Bonte J., De Loecker W. Effects of daily anti-estrogen treatment on uterine growth and progesterone receptor concentrations in adult rat uterus. Anticancer Res. 4:1984;157-162.
14. Limpongsanurak S., Jenkins N., Fotherby K. Effect of contraceptive steroids on serum levels of sex hormone binding globulin and caeruloplasmin. Curr. Med. Res. Opin. 7:1981;185-191.
15. Majid E., Senior J. Anti-oestrogen modification of uterine responses to oestrogen in the rat. J. Reprod. Fertil. 66:1982;79-85.
16. McCarthy M., Schlenker E., Pfaff D. Enduring consequences of neonatal treatment with anitsense oligodeoxynucleotides to estrogen receptor messenger ribonucleic acid on sexual differentiation of rat brain. Endocrinology. 133:1993;433-439.
17. McKenna S.E., Simon N.G., Cologer-Clifford A. An assessment of agonist/antagonist effects of tamoxifen in the female mouse brain. Horm. Behav. 26:1992;536-544.
18. Moffatt C.A., Rissman E.F., Shupnik M.A., Blaustein J.D. Induction of progestin receptors by estradiol in the forebrain of estrogen receptor-α gene disrupted mice. J. Neurosci. 18:1998;9556-9563.
19. Murphy C.S., Jordan V.C. Structural components necessary for the antiestrogenic activity of tamoxifen. J. Steroid Biochem. 34:1989;407-411.
20. Patisaul H., Whitten P., Young L. Regulation of estrogen receptor beta mRNA in the brain: opposite effects of 17β-estradiol and the phytoestrogen, coumestrol. Brain Res. Mol. Brain Res. 67:1999;165-171.
21. Patisaul H.B., Dindo M., Whitten P.L., Young L.J. Soy isoflavone supplements antagonize reproductive behavior and ERα- and ERβ-dependent gene expression in the brain. Endocrinology. 142:2001.
22. Patisaul H.B., Melby M., Whitten P.L., Young L.J. Genistein affects ERβ- but not ERα-dependent gene expression in the hypothalamus. Endocrinology. 143:2002;2189-2197.
23. Pinilla L., Barreiro M.L., Gonzalez L.C., Tena-Sempere M., Aguilar E. Comparative effects of testosterone propionate, oestradiol benzoate, ICI 182,780, tamoxifen and raloxifene on hypothalamic differentiation in the female rat. J. Endocrinol. 172:2002;441-448.
24. Pluss J.L., DiBella N.J. Reversible central nervous system dysfunction due to tamoxifen in a patient with breast cancer. Ann. Intern. Med. 101:1984;652.
25. Sanchez-Criado J.E., Guelmes P., Bellido C., Gonzalez M., Hernandez G., Aguilar R., Garrido-Gracia J.C., Bello A.R., Alonso R. Tamoxifen but not other selective estrogen receptor modulators antagonizes estrogen actions on luteinizing hormone secretion while inducing gonadotropin-releasing hormone self-priming in the rat. Neuroendocrinology. 76:2002;203-213.
26. Shughrue P., Lubahn D., Negro-Vilar A., Korack K., Merchenthaler I. Responses in the brain of estrogen receptor α-disrupted mice. Proc. Natl. Acad. Sci. USA. 94:1997;11008-11012.
27. Shughrue P., Merchenthaler I. Distribution of estrogen receptor beta immunoreactivity in the rat central nervous system. J. Comp. Neurol. 436:2001;64-81.
28. Shughrue P.J., Komm B., Merchenthaler I. The distribution of estrogen receptor-β mRNA in the rat hypothalamus. Steroids. 61:1996;678-681.
29. Shughrue P.L., Lane M.V., Merchenthaler I. Comparative distribution of estrogen receptor α and β mRNA in the rat central nervous system. J. Comp. Neurol. 388:1997;507-525.
30. Shughrue P.L., Lane M.V., Merchenthaler I. Regulation of progesterone receptor messenger ribonucleic acid in the rat medial preoptic nucleus by estrogenic and antiestrogenic compounds: an in situ hybridization study. Endocrinology. 138:1997;5476-5484.
31. Thigpen J., Setchell K., Ahlmark K., Locklear J., Spahr T., Caviness G., Goelz M., Haseman J., Newbold R., Forsythe D. Phytoestrogen content of purified open- and closed-formula laboratory animal diets. Lab. Anim. Sci. 49:1999;530-536.
32. Wang Z.X., Liu Y., Young L.J., Insel T.R. Hypothalamic vasopressin gene expression increases in both males and females postpartum in a biparental rodent. J. Neuroendocrinol. 12:2000;111-120.
33. Watanabe T., Inoue S., Ogawa S., Ishii Y., Hiroi H., Ikeda K., Orimo A., Muramatsu M. Agonistic effect of tamoxifen is dependent on cell type, ERE-promoter context and estrogen receptor subtype: functional difference between estrogen receptors α and β Biochem. Biophys. Res. Commun. 236:1997;140-145.
34. Webb P., Lopez G.N., Uht R.M., Kushner P.J. Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol. Endocrinol. 9:1995;443-456.
35. Young L.J., Wang Z., Donaldson R., Rissman E.F. Estrogen receptor α is essential for induction of oxytocin receptor by estrogen. Neuroreport. 9:1998;933-936.
36. Young W.C., Goy R.W., Phoinis C.H. Hormones and sexual behavior. Science. 143:1964;212-218.
37. Zhou W., Koldzic-Zivanovic N., Clarke C.H., de Beun R., Wassermann K., Bury P.S., Cunningham K.A., Thomas M.L. Selective estrogen receptor modulator effects in the rat brain. Neuroendocrinology. 75:2002;24-33.